PlexPCR - Model SARS-CoV-2 - COVID-19 Causative Coronavirus
Detect COVID-19 causative coronavirus, SARS-CoV-2; Multiplex RT-qPCR test with dual targets (RdRp/ORF1ab) and RNA-based internal control in a single-well. Scalable solution supporting surge capacity.
As SARS-CoV-2 continues to mutate, giving rise to variants potentially impacting diagnostic testing, laboratories need continued confidence in the results they are reporting. We routinely monitor the performance of our PlexPCR® SARS-CoV-2 assay against emerging variants to ensure you can continue to report patient test data with no hesitation.§
- Routine in silico analysis of primer sets against a database of all available SARS-CoV-2 sequences – in accordance with global government organisation recommendations, including Medicine & Healthcare products Regulatory Agency (MHRA)
- View data on variant analysis against the PlexPCR® SARS-CoV-2 assay here
PlexPCR® SARS-CoV-2 is a dual-target, single-well, multiplex reverse transcriptase qPCR test for the detection of COVID-19 causing coronavirus (SARS-CoV-2) plus RNA internal control
Targets
Well 1: ORF1ab, RdRp, RNA internal control
Sample types
Swabs: nasopharyngeal swabs only and saliva*
Amplification instrument
- Roche LightCycler® 480 Instrument II (LC480 II)
- Bio-Rad CFX96™ Dx (CFX96 Dx)
- Bio-Rad CFX96™ Touch™ (CFX96 Touch)
*Saliva samples are not commercially available for use in UK.
Shipping Conditions
Products are shipped on dry ice or ice gel packs.
Storage & stability
Expiry dates are stated on the labels. It is recommended that freeze/thaw cycles be limited to less than 10. Store protected from light at – 25°C to – 15°C.
Intended use
For in vitro diagnostic use. Not for sale in the USA.
Regulatory status
CE-IVD, TGA cleared
The COVID-19 pandemic has impacted testing laboratories globally. Increased testing demands, disruptions in supply, or fluctuations in staffing due to self-isolation practices all have an effect on laboratory efficiency.
PlexPCR® SARS-CoV-2 can help your laboratory work effectively.
- Security of supply with PlexPCR® – our unique technology de-couples the detection probe from the target sequence. We routinely produce and stockpile large volumes of test reagents to support high volume ordering fluctuations, ensuring no interruptions to your daily laboratory testing.
- Clinically relevant turnaround times – conserved dual target sequence not impacted by current circulating variants,§ eliminating the need for repeat or confirmation testing by sequencing.
- Streamlined workflow – compatible with robotic liquid handlers including SpeeDx PlexPrep™, an automated and intuitive instrument that alleviates laboratory staffing pressures or constraints.
Automation compatible workflow to maintain clinically relevant turnaround times. Includes license free, validated SpeeDx analysis software for automated result calling and simple, simultaneous data processing of large sample numbers.
- Scalable throughput for surge testing – easily adapt to local testing demands caused by a sudden surge in suspected COVID-19 cases.
- Flexibility in the laboratory – scale throughput up or down from 480 to 1920 samples in an 8hr shift with automated software analysis and PlexPrep™ liquid handler robotics*